Biodesix, Inc. (BDSX) Balance Sheet
BDSX balance sheet, 2025
December 31, 2025 · U.S. dollars$87.5M assets = $89.9M liabilities + −$2.5M equity
Liabilities exceed assets: shareholders’ equity is negative (−$2.5M).
Both columns are drawn to the same scale: what BDSX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BDSX financial health
Descriptive bands, not a rating. Fiscal 2025.
BDSX balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $39.1M2018 | $87.5M2025 | +12.2%/yr | |
| Total liabilities | $237.1M2018 | $89.9M2025 | −12.9%/yr | |
| Shareholders’ equity | −$198.0M2018 | −$2.5M2025 | — | |
| Cash & short-term investments | $5.9M2018 | $19.0M2025 | +18.1%/yr | |
| Total debt | $23.1M2018 | $72.9M2025 | +17.8%/yr | |
| Net cash (debt) | −$17.2M2018 | −$53.9M2025 | −$36.7M | |
| Working capital | $5.4M2018 | $15.1M2025 | +$9.6M | |
| Book value per share | $1.122023 | −$0.332025 | — | |
| Current ratio | 2.222018 | 1.862025 | −0.35 | |
| Debt / equity | 0.672020 | 2.972024 | +2.29 | |
| Shares outstanding | 4.1M2023 | 7.6M2025 | +35.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BDSX assets
BDSX liabilities and equity
BDSX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BDSX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $19.0M | $26.2M | $26.3M | $43.1M | $32.7M | $62.1M | $5.3M | $5.9M |
| Cash & equivalents | $19.0M | $26.2M | $26.3M | $43.1M | $32.7M | $62.1M | $5.3M | $5.9M |
| Receivables | $9.0M | $8.6M | $7.7M | $5.1M | $3.7M | $15.3M | $5.3M | $1.9M |
| Inventory | $0 | $0 | $1.4M | $1.4M | $2.9M | $3.2M | $800,000 | $700,000 |
| Other current assets | $4.5M | $4.6M | $4.3M | $3.8M | $4.3M | $5.5M | $1.3M | $1.4M |
| Total current assets | $32.5M | $39.5M | $39.7M | $53.3M | $43.6M | $86.1M | $12.7M | $9.9M |
| Property, plant & equipment (net) | $27.8M | $29.6M | $29.6M | $8.8M | $4.2M | $3.2M | $2.1M | $1.4M |
| Goodwill & intangible assets | $18.9M | $20.9M | $22.9M | $24.8M | $26.6M | $28.3M | $26.7M | $27.7M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $8.2M | $7.3M | $6.9M | $5.9M | $1.7M | $3.5M | $90,000 | $99,000 |
| Total assets | $87.5M | $97.2M | $99.1M | $92.9M | $76.1M | $121.1M | $41.6M | $39.1M |
| Liabilities | ||||||||
| Accounts payable | $3.1M | $2.2M | $2.9M | $1.7M | $1.7M | $9.0M | $1.7M | $886,000 |
| Short-term debt | $1.4M | $740,000 | $303,000 | $1.6M | $19,000 | $11.8M | $12.2M | — |
| Deferred revenue | $961,000 | $678,000 | $324,000 | $962,000 | $1.9M | $3.5M | $1.3M | $492,000 |
| Total current liabilities | $17.4M | $14.3M | $33.4M | $22.8M | $29.0M | $32.1M | $22.6M | $4.5M |
| Long-term debt | $47.4M | $36.4M | $35.2M | $25.0M | $10.0M | $15.9M | $23.8M | $23.1M |
| Lease obligations | $25.4M | $25.5M | $25.4M | $6.8M | $0 | — | — | — |
| Other long-term liabilities | $25.1M | $25.6M | $25.9M | $24.5M | $17.4M | $31.9M | $223.8M | $209.5M |
| Total liabilities | $89.9M | $76.4M | $94.5M | $72.3M | $56.4M | $79.9M | $270.2M | $237.1M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $8,000 | $145,000 | $96,000 | $78,000 | $31,000 | $27,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$497.8M | −$462.5M | −$419.6M | −$367.4M | −$302.0M | −$258.8M | −$230.9M | −$200.1M |
| Accumulated other comprehensive income | — | — | $0 | $0 | $0 | −$121.1M | −$194.0M | −$5.6M |
| Total shareholders' equity | −$2.5M | $20.9M | $4.6M | $20.6M | $19.7M | $41.2M | −$228.5M | −$198.0M |
| Key figures | ||||||||
| Total debt | $72.9M | $62.0M | $60.7M | $31.9M | $10.0M | $27.8M | $36.0M | $23.1M |
| Net cash (debt) | −$53.9M | −$35.7M | −$34.4M | $11.2M | $22.7M | $34.4M | −$30.7M | −$17.2M |
| Working capital | $15.1M | $25.2M | $6.3M | $30.5M | $14.7M | $54.0M | −$9.9M | $5.4M |
| Tangible book value | −$21.4M | −$29,000 | −$18.4M | −$4.2M | −$6.9M | $12.9M | −$255.3M | −$225.7M |
| Book value per share | −$0.33 | $3.22 | $1.12 | — | — | — | — | — |
| Shares outstanding | 7.6M | 6.5M | 4.1M | — | — | — | — | — |
| Current ratio | 1.86 | 2.76 | 1.19 | 2.34 | 1.51 | 2.68 | 0.56 | 2.22 |
| Quick ratio | 1.61 | 2.43 | 1.02 | 2.11 | 1.26 | 2.41 | 0.47 | 1.75 |
| Debt / equity | — | 2.97 | 13.25 | 1.55 | 0.51 | 0.67 | — | — |
| Equity / assets | −2.8% | 21.5% | 4.6% | 22.2% | 25.9% | 34.0% | −548.9% | −507.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $30.0M | $25.6M | $19.0M | $16.7M | $20.7M | $17.6M | $26.2M | $31.4M | $42.2M | $11.5M | $26.3M | $19.8M |
| Cash & equivalents | $30.0M | $25.6M | $19.0M | $16.7M | $20.7M | $17.6M | $26.2M | $31.4M | $42.2M | $11.5M | $26.3M | $19.8M |
| Receivables | $9.2M | $9.5M | $9.0M | $12.7M | $7.5M | $7.6M | $8.6M | $8.0M | $10.1M | $9.9M | $7.7M | $5.8M |
| Inventory | $0 | $0 | $0 | $1.4M | $0 | $0 | $0 | $1.2M | $1.2M | $1.4M | $1.4M | $1.3M |
| Other current assets | $4.4M | $5.8M | $4.5M | $2.6M | $4.3M | $4.4M | $4.6M | $3.4M | $4.0M | $5.7M | $4.3M | $2.0M |
| Total current assets | $43.6M | $40.9M | $32.5M | $33.4M | $32.4M | $29.6M | $39.5M | $44.0M | $57.6M | $28.5M | $39.7M | $28.9M |
| Property, plant & equipment (net) | $27.3M | $27.4M | $27.8M | $30.7M | $28.2M | $28.9M | $29.6M | $30.6M | $29.8M | $30.1M | $29.6M | $27.5M |
| Goodwill & intangible assets | $18.0M | $18.5M | $18.9M | $19.4M | $19.9M | $20.4M | $20.9M | $21.5M | $21.9M | $22.4M | $22.9M | $23.4M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $6.4M | $7.9M | $8.2M | $5.2M | $7.2M | $7.3M | $7.3M | $6.7M | $6.6M | $6.2M | $6.9M | $7.0M |
| Total assets | $95.3M | $94.6M | $87.5M | $88.7M | $87.7M | $86.2M | $97.2M | $102.7M | $115.8M | $87.2M | $99.1M | $86.8M |
| Liabilities | ||||||||||||
| Accounts payable | $2.2M | $3.7M | $3.1M | $3.6M | $3.0M | $2.9M | $2.2M | $2.5M | $2.2M | $3.2M | $2.9M | $2.9M |
| Short-term debt | $1.6M | $1.5M | $1.4M | $1.4M | $1.2M | $1.1M | $740,000 | $653,000 | $337,000 | $317,000 | $303,000 | $1.2M |
| Deferred revenue | $205,000 | $223,000 | $961,000 | $2.8M | $617,000 | $788,000 | $678,000 | $676,000 | $447,000 | $313,000 | $324,000 | $659,000 |
| Total current liabilities | $15.3M | $14.5M | $17.4M | $18.2M | $15.2M | $13.3M | $14.3M | $13.0M | $17.6M | $31.2M | $33.4M | $32.6M |
| Long-term debt | $46.8M | $46.5M | $47.4M | $47.1M | $46.8M | $36.7M | $36.4M | $36.1M | $35.8M | $35.5M | $35.2M | $24.9M |
| Lease obligations | $25.0M | $25.1M | $25.4M | $25.8M | $25.3M | $25.6M | $25.5M | $25.8M | $25.8M | $25.6M | $25.4M | $25.7M |
| Other long-term liabilities | $24.1M | $24.5M | $25.1M | $25.2M | $24.7M | $25.2M | $27.6M | $25.8M | $26.2M | $26.0M | $25.9M | $30.6M |
| Total liabilities | $86.2M | $85.5M | $89.9M | $90.4M | $86.6M | $75.2M | $76.4M | $74.9M | $79.6M | $92.7M | $94.5M | $88.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $11,000 | $10,000 | $8,000 | $8,000 | $146,000 | $146,000 | $145,000 | $145,000 | $145,000 | $97,000 | $96,000 | $88,000 |
| Retained earnings (deficit) | −$512.8M | −$505.6M | −$497.8M | −$493.8M | −$485.1M | −$473.6M | −$462.5M | −$454.2M | −$444.0M | −$433.2M | −$419.6M | −$410.4M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $9.1M | $9.1M | −$2.5M | −$1.7M | $1.1M | $11.1M | $20.9M | $27.9M | $36.3M | −$5.5M | $4.6M | −$1.4M |
| Key figures | ||||||||||||
| Total debt | $71.8M | $71.6M | $72.9M | $72.9M | $72.1M | $62.3M | $62.0M | $62.0M | $61.6M | $61.2M | $60.7M | $50.7M |
| Net cash (debt) | −$41.8M | −$46.0M | −$53.9M | −$56.2M | −$51.4M | −$44.7M | −$35.7M | −$30.6M | −$19.4M | −$49.7M | −$34.4M | −$30.9M |
| Working capital | $28.3M | $26.4M | $15.1M | $15.2M | $17.3M | $16.3M | $25.2M | $31.1M | $40.0M | −$2.8M | $6.3M | −$3.8M |
| Tangible book value | −$8.9M | −$9.3M | −$21.4M | −$21.1M | −$18.8M | −$9.3M | −$29,000 | $6.4M | $14.3M | −$27.9M | −$18.4M | −$24.9M |
| Book value per share | $0.89 | $0.95 | −$0.31 | −$0.23 | $0.16 | $1.51 | $2.85 | $3.81 | $5.70 | −$1.13 | $0.99 | −$0.36 |
| Shares outstanding | 10.3M | 9.7M | 8.1M | 7.5M | 7.3M | 7.3M | 7.3M | 7.3M | 6.4M | 4.9M | 4.6M | 4.0M |
| Current ratio | 2.85 | 2.82 | 1.86 | 1.84 | 2.14 | 2.22 | 2.76 | 3.40 | 3.28 | 0.91 | 1.19 | 0.88 |
| Quick ratio | 2.56 | 2.42 | 1.61 | 1.62 | 1.86 | 1.90 | 2.43 | 3.04 | 2.98 | 0.68 | 1.02 | 0.78 |
| Debt / equity | 7.85 | 7.84 | — | — | 63.39 | 5.63 | 2.97 | 2.22 | 1.70 | — | 13.25 | — |
| Equity / assets | 9.6% | 9.6% | −2.8% | −1.9% | 1.3% | 12.8% | 21.5% | 27.1% | 31.3% | −6.3% | 4.6% | −1.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.
BDSX financial position
At the end of fiscal 2025 (December 31, 2025), Biodesix had total assets of $87.5 million (down 10.0% from a year earlier), total liabilities of $89.9 million and shareholders' equity of -$2.5 million. It held $19.0 million in cash and short-term investments against $72.9 million of debt, net debt of $53.9 million. Its current ratio was 1.86. In the latest quarter (ended June 30, 2026) total assets were $95.3 million and equity $9.1 million.
Related: BDSX income statement, BDSX cash flow statement, BDSX key metrics. See the BDSX stock overview for the latest quote and news.
BDSX balance sheet FAQ
What are Biodesix's total assets?
Biodesix reported total assets of $87.5 million at the end of fiscal 2025 (December 31, 2025), compared with $97.2 million a year earlier.
How much debt does Biodesix have?
Biodesix had $72.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Biodesix have?
Biodesix held $19.0 million in cash and short-term investments at the end of fiscal 2025; with $72.9 million of debt that is net debt of $53.9 million.
What is Biodesix's book value?
Biodesix's shareholders' equity (book value) was -$2.5 million at the end of fiscal 2025, or −$0.33 per share.
What is Biodesix's current ratio?
Biodesix had current assets of $32.5 million and current liabilities of $17.4 million, a current ratio of 1.86 (it can cover its short-term obligations).
How much goodwill does Biodesix have?
Biodesix carried $18.9 million of goodwill and intangible assets, 21.6% of total assets, at the end of fiscal 2025.